1. Home
  2. CSLR vs CINGW Comparison

CSLR vs CINGW Comparison

Compare CSLR & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSLR
  • CINGW
  • Stock Information
  • Founded
  • CSLR 2022
  • CINGW N/A
  • Country
  • CSLR United States
  • CINGW United States
  • Employees
  • CSLR N/A
  • CINGW 13
  • Industry
  • CSLR Semiconductors
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSLR Technology
  • CINGW Health Care
  • Exchange
  • CSLR Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • CSLR N/A
  • CINGW N/A
  • IPO Year
  • CSLR N/A
  • CINGW 2021
  • Fundamental
  • Price
  • CSLR $1.61
  • CINGW $0.03
  • Analyst Decision
  • CSLR Buy
  • CINGW
  • Analyst Count
  • CSLR 1
  • CINGW 0
  • Target Price
  • CSLR $6.00
  • CINGW N/A
  • AVG Volume (30 Days)
  • CSLR 499.1K
  • CINGW N/A
  • Earning Date
  • CSLR 11-13-2024
  • CINGW N/A
  • Dividend Yield
  • CSLR N/A
  • CINGW N/A
  • EPS Growth
  • CSLR N/A
  • CINGW N/A
  • EPS
  • CSLR N/A
  • CINGW N/A
  • Revenue
  • CSLR $40,797,000.00
  • CINGW N/A
  • Revenue This Year
  • CSLR N/A
  • CINGW N/A
  • Revenue Next Year
  • CSLR $220.32
  • CINGW N/A
  • P/E Ratio
  • CSLR N/A
  • CINGW N/A
  • Revenue Growth
  • CSLR N/A
  • CINGW N/A
  • 52 Week Low
  • CSLR $0.20
  • CINGW N/A
  • 52 Week High
  • CSLR $3.37
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • CSLR 38.81
  • CINGW N/A
  • Support Level
  • CSLR $1.54
  • CINGW N/A
  • Resistance Level
  • CSLR $1.76
  • CINGW N/A
  • Average True Range (ATR)
  • CSLR 0.12
  • CINGW 0.00
  • MACD
  • CSLR -0.01
  • CINGW 0.00
  • Stochastic Oscillator
  • CSLR 25.85
  • CINGW 0.00

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: